AcquisitionOther
Carmell Corp acquired Flagstaff-based Axolotl Biologix, a profitable regenerative medicine company developing products
Public deal record from 8-K. The source names the buyer and target, and terms are shown only when the filing or announcement discloses them.
Deal tape row
Carmell Corp -> Flagstaff-based Axolotl Biologix, a profitable regenerative medicine company developing products · $65 million
Josh Sandberg, CEO of Axolotl who shall serve as Strategic Advisor to the Executive Chairman of Carmell.
Open source record (SEC) ↗